非オピオイド性疼痛パッチ市場：パッチタイプ、適応症、流通別-2025-2030年世界予測

非オピオイド性疼痛パッチ市場は、2023年に7億129万米ドルと評価され、2024年には7億9,097万米ドルに達すると予測され、CAGR 12.88％で成長し、2030年には16億3,777万米ドルに達すると予測されています。

非オピオイド鎮痛パッチ市場は、オピオイドの使用を避け、薬剤や代替療法の経皮投与によって痛みを緩和するように設計された製品に焦点を当てています。これらのパッチは、オピオイド中毒の危機の中で、より安全な疼痛管理ソリューションに対する需要の高まりに対応するために極めて重要です。慢性疼痛管理から術後ケアまでさまざまな場面で用途があり、病院、診療所、在宅ケアなどの最終用途環境で汎用性があります。市場の成長は、慢性疼痛疾患の有病率の増加、製剤技術の進歩、非中毒性疼痛緩和ソリューションに対する意識の高まりによって促進されます。主なビジネスチャンスは、非オピオイドの選択肢に関する啓蒙キャンペーンによるユーザーベースの拡大、より広範な採用のためのヘルスケアプロバイダーとの提携、ドラッグデリバリーの効率を高める次世代パッチの技術活用にあります。しかし、市場は厳しい規制要件、高い市場開拓コスト、従来の疼痛緩和方法との競合といった課題に直面しています。このような課題がある中、重要な技術革新分野としては、粘着性と快適性を向上させる新規パッチ素材の開発や、個別化された疼痛管理のためのデジタルヘルス機能の統合の検討などが挙げられます。市場の維持と成長のためには、企業は強力な研究開発能力の構築、コスト削減のためのサプライチェーンの最適化、市場浸透のための戦略的提携に注力すべきです。予防ヘルスケアと個別化医療への移行動向は、大きな成長の道筋を示しており、市場教育とエビデンスに基づくパッチの有効性検証の重要性を浮き彫りにしています。市場競争力を維持するためには、規制状況を巧みに操り、ホリスティックで低侵襲な治療に対する消費者の嗜好の変化に適応することが不可欠です。こうした力学を読み解くことで、企業は効果的な戦略を立て、成長の障壁を克服し、進化する非オピオイド疼痛管理分野における新たな機会を捉えることができます。

市場力学：急速に進化する非オピオイド性疼痛パッチ市場の主要市場インサイトを公開

非オピオイド性疼痛パッチ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性および急性疼痛関連疾患の増加
  • 非オピオイドパッチに対するヘルスケア専門家の志向の高まり
  • 非オピオイド性疼痛パッチが従来の薬よりももたらすメリット
• 市場抑制要因
  • 非オピオイド性疼痛パッチの認知度の低さ
• 市場機会
  • 非中毒性疼痛治療ソリューションに対する政府の好意的な取り組み
  • 疼痛管理治療における研究開発の活発化
• 市場の課題
  • 重大な副作用と代替治療の利用可能性

ポーターの5つの力：非オピオイド性疼痛パッチ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：非オピオイド性疼痛パッチ市場における外部からの影響の把握

外部マクロ環境要因は、非オピオイド性疼痛パッチ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析非オピオイド性疼痛パッチ市場における競合情勢の把握

非オピオイド性疼痛パッチ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス非オピオイド性疼痛パッチ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、非オピオイド性疼痛パッチ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨非オピオイド性疼痛パッチ市場における成功への道筋を描く

非オピオイド性疼痛パッチ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性および急性の疼痛関連疾患の増加
    • ヘルスケア従事者の非オピオイドパッチへの関心の高まり
    • 従来の医薬品と比較した非オピオイド性疼痛パッチの利点
  • 抑制要因
    • 非オピオイド性疼痛パッチに関連する認識の制限
  • 機会
    • 非依存性疼痛治療ソリューションに向けた政府の好ましい取り組み
    • 疼痛管理治療における研究開発の増加
  • 課題
    • 重大な副作用と代替治療法の可用性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 非オピオイド性疼痛パッチ市場パッチタイプ別

• カプサイシンパッチ
• ジクロフェナクパッチ
• ケトプロフェンパッチ
• リドカインパッチ
• メチルサリチル酸パッチ

第7章 非オピオイド性疼痛パッチ市場適応症別

• 関節炎
• 腰痛
• 線維筋痛症
• 偏頭痛と頭痛
• 筋肉の緊張と捻挫
• 帯状疱疹後神経痛

第8章 非オピオイド性疼痛パッチ市場配布元

• ドラッグストア
• 病院
• オンライン薬局

第9章 南北アメリカの非オピオイド性疼痛パッチ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の非オピオイド性疼痛パッチ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの非オピオイド性疼痛パッチ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Bridges Consumer Healthcare, LLC
• Cardinal Health, Inc.
• Endo International plc
• GlaxoSmithKline Plc.
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson Services, Inc.
• Pfizer Inc.
• Sanofi S.A.
• SCILEX Pharmaceuticals Inc.
• Sorrento Therapeutics, Inc.
• Teh Seng Pharmaceutical Mfg. Co., Ltd.
• Teikoku Seiyaku Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Veridian Healthcare
• Virpax Pharmaceuticals, Inc.

LIST OF FIGURES

• FIGURE 1. NON-OPIOID PAIN PATCHES MARKET RESEARCH PROCESS
• FIGURE 2. NON-OPIOID PAIN PATCHES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NON-OPIOID PAIN PATCHES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NON-OPIOID PAIN PATCHES MARKET DYNAMICS
• TABLE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 51. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 52. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 54. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 106. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 118. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 119. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 120. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 121. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 122. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 151. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 152. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

The Non-opioid Pain Patches Market was valued at USD 701.29 million in 2023, expected to reach USD 790.97 million in 2024, and is projected to grow at a CAGR of 12.88%, to USD 1,637.77 million by 2030.

The non-opioid pain patch market focuses on products designed to alleviate pain through transdermal delivery of medications and alternative therapies, avoiding the use of opioids. These patches are crucial for addressing the growing demand for safer pain management solutions amid opioid addiction crises. They find applications in various settings, from chronic pain management to post-operative care, making them versatile in end-use environments such as hospitals, clinics, and home care. Market growth is propelled by an increasing prevalence of chronic pain disorders, advancements in formulation technologies, and heightened awareness of non-addictive pain relief solutions. Key opportunities lie in expanding the user base through awareness campaigns about non-opioid options, partnerships with healthcare providers for wider adoption, and leveraging technology for next-generation patches that enhance drug delivery efficiency. However, the market faces challenges such as stringent regulatory requirements, high development costs, and competition from traditional pain relief methods. Amid these challenges, crucial innovation areas include developing novel patch materials that improve adhesion and comfort, as well as exploring the integration of digital health features for personalized pain management. For market sustenance and growth, companies should focus on building strong R&D capabilities, optimizing supply chains to reduce costs, and engaging in strategic collaborations for market penetration. Transitioning trends towards preventive healthcare and personalized medicine present significant growth avenues, highlighting the importance of market education and evidence-based validation of patch efficacy. It's essential that market players navigate regulatory landscapes adeptly and adapt to evolving consumer preferences for holistic and minimally invasive treatments to sustain competitiveness. Deciphering these dynamics will enable companies to strategize effectively, overcoming growth barriers and capturing emerging opportunities in the evolving non-opioid pain management sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Non-opioid Pain Patches Market

The Non-opioid Pain Patches Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Chronic and Acute Pain-Related Disorders
  • Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
  • Benefits Associated with Non-opioid Pain Patches over Conventional Medications
• Market Restraints
  • Limited Awareness Associated with Non-opioid Pain Patches
• Market Opportunities
  • Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
  • Rising R&D in Pain Management Treatments
• Market Challenges
  • Significant Side Effect Coupled with Availability of Alternative Treatments

Porter's Five Forces: A Strategic Tool for Navigating the Non-opioid Pain Patches Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Non-opioid Pain Patches Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Non-opioid Pain Patches Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Non-opioid Pain Patches Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Non-opioid Pain Patches Market

A detailed market share analysis in the Non-opioid Pain Patches Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Non-opioid Pain Patches Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Non-opioid Pain Patches Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Non-opioid Pain Patches Market

A strategic analysis of the Non-opioid Pain Patches Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-opioid Pain Patches Market, highlighting leading vendors and their innovative profiles. These include Bridges Consumer Healthcare, LLC, Cardinal Health, Inc., Endo International plc, GlaxoSmithKline Plc., Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi S.A., SCILEX Pharmaceuticals Inc., Sorrento Therapeutics, Inc., Teh Seng Pharmaceutical Mfg. Co., Ltd., Teikoku Seiyaku Co. Ltd., Teva Pharmaceutical Industries Ltd., Veridian Healthcare, and Virpax Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Non-opioid Pain Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Patch Type, market is studied across Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches, Lidocaine Patches, and Methyl Salicylate Patches.
• Based on Indication, market is studied across Arthritis, Back Pain, Fibromyalgia, Migraines & Headaches, Muscle Strain & Sprains, and Post-Herpetic Neuralgia.
• Based on Distribution, market is studied across Drug Stores, Hospitals, and Online Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Chronic and Acute Pain-Related Disorders
    • 5.1.1.2. Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
    • 5.1.1.3. Benefits Associated with Non-opioid Pain Patches over Conventional Medications
  • 5.1.2. Restraints
    • 5.1.2.1. Limited Awareness Associated with Non-opioid Pain Patches
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
    • 5.1.3.2. Rising R&D in Pain Management Treatments
  • 5.1.4. Challenges
    • 5.1.4.1. Significant Side Effect Coupled with Availability of Alternative Treatments
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Non-opioid Pain Patches Market, by Patch Type

• 6.1. Introduction
• 6.2. Capsaicin Patches
• 6.3. Diclofenac Patches
• 6.4. Ketoprofen Patches
• 6.5. Lidocaine Patches
• 6.6. Methyl Salicylate Patches

7. Non-opioid Pain Patches Market, by Indication

• 7.1. Introduction
• 7.2. Arthritis
• 7.3. Back Pain
• 7.4. Fibromyalgia
• 7.5. Migraines & Headaches
• 7.6. Muscle Strain & Sprains
• 7.7. Post-Herpetic Neuralgia

8. Non-opioid Pain Patches Market, by Distribution

• 8.1. Introduction
• 8.2. Drug Stores
• 8.3. Hospitals
• 8.4. Online Pharmacies

9. Americas Non-opioid Pain Patches Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Non-opioid Pain Patches Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Non-opioid Pain Patches Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bridges Consumer Healthcare, LLC
• 2. Cardinal Health, Inc.
• 3. Endo International plc
• 4. GlaxoSmithKline Plc.
• 5. Hisamitsu Pharmaceutical Co., Inc.
• 6. Johnson & Johnson Services, Inc.
• 7. Pfizer Inc.
• 8. Sanofi S.A.
• 9. SCILEX Pharmaceuticals Inc.
• 10. Sorrento Therapeutics, Inc.
• 11. Teh Seng Pharmaceutical Mfg. Co., Ltd.
• 12. Teikoku Seiyaku Co. Ltd.
• 13. Teva Pharmaceutical Industries Ltd.
• 14. Veridian Healthcare
• 15. Virpax Pharmaceuticals, Inc.